NEWS

Washington Post: Upbeat news on a possible coronavirus treatment powers U.S. stocks, lifting Dow more than 500 points

Category: Business News

Small but significant scientific advances against covid-19 sent stocks bursting upward Wednesday, all but ignoring sobering data that shows a U.S. economy in paralysis. Stocks are on pace for one of their best months in decades as the United States ramps up coronavirus testing and states take steps to emerge from the weeks-long lockdown. Wednesday’s rally picked […]

Source: Washington Post

Keeping Trade Open: Where Do US Medical Products Really Come From?

Category: Business News

The COVID-19 pandemic has inflicted a heavy toll on the United States in lost lives and mounting economic hardship. While our resilience is unquestionable, the pandemic has laid bare the inadequacies of some aspects of U.S. preparedness, and policy changes are clearly warranted. But will we embrace the right solutions?  A number of lawmakers have […]

Source: US Chamber

Press Release: Roche develops new serology test to detect COVID-19 antibodies

Category: Business News

The new Elecsys Anti-SARS-CoV-2 serology test can support the detection of antibodies against SARS-CoV-2 in patients who have been exposed to the virus which causes COVID-19 The detection of these antibodies could help indicate if a person has gained immunity against the virus and inform treatment decisions Roche aims to have this test available by […]

Source: Roche

World Oil: ExxonMobil joins COVID-19 fight, helping develop multi-use PPE for clinical settings

Category: Business News

IRVING, TEXAS – ExxonMobil and the Global Center for Medical Innovation (GCMI) have initiated multi-sector and joint development projects to rapidly redesign and manufacture reusable personal protection equipment for health care workers, such as face shields and masks, which are in short supply as a result of the COVID-19 pandemic. In response to the unprecedented […]

Source: World Oil

Published: April 2, 2020

Press Release: Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

Category: Business News

Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020 Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capabilities and Additional Production Capacity Outside the U.S. to Begin Production […]

Source: Johnson & Johnson